Osaic Holdings
CTXR icon

Osaic Holdings’s Citius Pharmaceuticals CTXR Stock Holding History

Osaic Holdings’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.46K Buy
2,735
+1,248
+84% +$1.01K ﹤0.01% 6976
2025
Q4 		$1.16K Hold
1,487
– – ﹤0.01% 7231
2025
Q3 		$1.98K Sell
1,487
-200
-12% -$279 ﹤0.01% 7137
2025
Q2 		$2.68K Buy
1,687
+160
+10% +$147 ﹤0.01% 6829
2025
Q1 		$2.27K Hold
1,527
– – ﹤0.01% 6540
2024
Q4 		$6.11K Sell
1,527
-35,746
-96% -$241K ﹤0.01% 6079
2024
Q3 		$466K Sell
37,273
-20
-0.1% -$337 ﹤0.01% 2935
2024
Q2 		$544K Hold
37,293
– – ﹤0.01% 2704
2024
Q1 		$837K Buy
37,293
+3
+0% +$55 ﹤0.01% 2507
2023
Q4 		$705K Buy
37,290
+34,394
+1,188% +$652K ﹤0.01% 2859
2023
Q3 		$49.6K Buy
2,896
+1,268
+78% +$30.1K ﹤0.01% 5012
2023
Q2 		$48.8K Buy
1,628
+42
+3% +$1.38K ﹤0.01% 4953
2023
Q1 		$46.4K Sell
1,586
-240
-13% -$6.92K ﹤0.01% 5006
2022
Q4 		$36.2K Buy
1,826
+360
+25% +$9.82K ﹤0.01% 5166
2022
Q3 		$44K Buy
1,466
+80
+6% +$2.2K ﹤0.01% 5008
2022
Q2 		$32K Hold
1,386
– – ﹤0.01% 5284
2022
Q1 		$62K Hold
1,386
– – ﹤0.01% 4933
2021
Q4 		$53K Sell
1,386
-120
-8% -$5.44K ﹤0.01% 5100
2021
Q3 		$76K Sell
1,506
-114
-7% -$5.72K ﹤0.01% 4767
2021
Q2 		$141K Sell
1,620
-1,340
-45% -$80.5K ﹤0.01% 4189
2021
Q1 		$131K Buy
2,960
+860
+41% +$34.2K ﹤0.01% 4139
2020
Q4 		$54K Buy
2,100
+1,900
+950% +$49.5K ﹤0.01% 4504
2020
Q3 		$5K Buy
+200
New +$5.65K ﹤0.01% 5554
2020
Q2 		– Sell
-40
Closed -$1K – 6145
2020
Q1 		$1K Buy
+40
New +$845 ﹤0.01% 5820

Other funds holding CTXR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
AAG
Asset Advisory Group Kinnelon, New Jersey $229M AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Osaic Holdings's CTXR Position: Q1 2026 in Review

Osaic Holdings increased its Citius Pharmaceuticals (CTXR) stake by 84% in Q1 2026, buying an estimated $1.01K and bringing the position to 2,735 shares worth $2.46K. The position accounts for ﹤0.01% of the portfolio, ranked #6976.

Osaic Holdings first reported a position in CTXR in Q1 2020 and has held it in 24 quarters since. The position peaked at $837K in Q1 2024. 38 funds tracked by Wall St. Rank hold CTXR as of Q1 2026.

  • Osaic Holdings held 2,735 shares of Citius Pharmaceuticals worth $2.46K as of Q1 2026.
  • Osaic Holdings bought 1,248 Citius Pharmaceuticals shares in Q1 2026, an estimated $1.01K.
  • Citius Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #6976 holding.
  • Osaic Holdings first reported a position in Citius Pharmaceuticals in Q1 2020 and has held it in 24 quarters since.
  • Osaic Holdings's Citius Pharmaceuticals position peaked at $837K in Q1 2024.
  • 38 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.